UNIC
SFDR Classification
SFDR 8

Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc

ISR Label
Latest NAV
12,2422 GBP
Performance YTD

2,36%

Assets Under Management
217mio GBP
TER
0,45%
ISIN
LU2023678282
Dividend Policy
Capitalisation
Investment Objective

The Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc is a UCITS compliant exchange traded fund that aims to track the MSCI ACWI IMI Disruptive technology ESG Filtered Index. The index aims to represent the performance of companies expected to derive significant revenue from areas like 3D printing, the ‘Internet of Things’, cloud computing, Fintech, digital payments, healthcare, robotics, clean energy and smart grids, and cybersecurity. The index methodology employs a set of key words of theme-related products, services and concepts built using natural language processing and data analysis techniques. These key words help identify relevant companies based on the proportion of revenue that can be linked to the Disruptive Technology theme. Annually, the expression of the high-level index objective and associated sub-themes are reviewed with the consultative input of a thematic industry expert retained by MSCI. The index is filtered based on MSCI ESG Ratings, controversy scores and certain business activities, with final stock weights based on a combined score of three fundamental metrics: 1-year sales growth, Return on Invested Capital, and % sales spent on R&D and Capex. Lyxor ETFs are efficient investment vehicles listed on exchange that offer transparent, liquid and low-cost exposure to the underlying benchmark index.

As announced in March 2020, effective October 1st, 2021, the TER was reset to its target level of 0.45%.

UNIC
SFDR Classification
SFDR 8

Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc

ISR Label

PERFORMANCE

Performance history

Legend:

The figures relating to [past performances / simulated past performances / past performances and simulated past performances] refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data.

Product 1Y
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc 10,07%
Benchmark Index 10,85%
Data as of 01/12/2021, Source: Lyxor International Asset Management
Product YTD 1M 3M 1Y 3Y 5Y 10Y ALL
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc 2,36% -5,88% -5,16% 10,07% - - - 59,74%
Benchmark Index 3,05% -5,73% -4,96% 10,85% - - - 61,15%
Data as of 01/12/2021, Source: Lyxor International Asset Management
Product 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc - - - - - - - - - -
Benchmark Index - - - - - - - - - -
Data as of 01/12/2021, Source: Lyxor International Asset Management

NAV History

Date NAV Currency Fund AUM
01/12/2021 12,1638 GBP 216mio GBP
30/11/2021 12,6085 GBP 224mio GBP
29/11/2021 12,667 GBP 242mio GBP
26/11/2021 12,6323 GBP 241mio GBP
25/11/2021 12,8292 GBP 245mio GBP

Dividend History

This fund does not distribute any dividend.

HOLDINGS


Name Currency Weight Sector Country
MIRATI THERAPEUTICS INC USD 1,84% Health Care United States
FATE THERAPEUTICS INC USD 1,71% Health Care United States
FULGENT GENETICS INC USD 1,55% Health Care United States
Inovio Pharmaceuticals Inc USD 1,55% Health Care United States
ANAPTYSBIO INC USD 1,46% Health Care United States
PROTHENA CORP PLC USD 1,37% Health Care Ireland
NOVAVAX INC USD 1,22% Health Care United States
ZAI LAB LTD-ADR USD 1,18% Health Care China
SQUARE INC - A USD 1,17% Information Technology United States
SUNNOVA ENERGY INTERNATIONAL USD 1,16% Utilities United States
Name Listing Currency Quantity Weight Sector Country
MIRATI THERAPEUTICS INC USD 39 953 1,84% Health Care United States
FATE THERAPEUTICS INC USD 94 040 1,71% Health Care United States
FULGENT GENETICS INC USD 53 173 1,55% Health Care United States
Inovio Pharmaceuticals Inc USD 674 615 1,55% Health Care United States
ANAPTYSBIO INC USD 134 559 1,46% Health Care United States
PROTHENA CORP PLC USD 84 417 1,37% Health Care Ireland
NOVAVAX INC USD 18 180 1,22% Health Care United States
ZAI LAB LTD-ADR USD 47 468 1,18% Health Care China
SQUARE INC - A USD 17 283 1,17% Information Technology United States
SUNNOVA ENERGY INTERNATIONAL USD 95 119 1,16% Utilities United States

This funds does not use sec/lending

Index Information

Full Name MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index
Index Type Performance
Index Bloomberg Ticker MXACDSRT
Index Currency USD
Number of Index Components 212
Further Information www.msci.com
Dividend Yield (%) 0,62
Data as of 01/12/2021

Index Composition Breakdown

Currency Breakdown

USD 75,77%
EUR 10,29%
CHF 3,04%
CAD 2,75%
Others 2,2%
AUD 1,77%
HKD 1,63%
CNH 1,02%
JPY 0,9%
SEK 0,64%

Sector Breakdown

Information Technology 49,04%
Health Care 36,69%
Industrials 5,43%
Utilities 3,79%
Communication Services 2,47%
Consumer Discretionary 1,21%
Financials 0,91%
Energy 0,37%
Materials 0,1%

Countries Breakdown

United States 71,47%
China 5,77%
Switzerland 3,33%
Germany 3,3%
France 2,32%
Canada 2,26%
Netherlands 1,69%
Ireland 1,37%
Belgium 1,33%
Australia 1,09%
Japan 0,9%
Puerto Rico 0,73%
Spain 0,7%
New Zealand 0,68%
Sweden 0,64%
Denmark 0,61%
Taiwan 0,59%
United Kingdom 0,59%
Thailand 0,21%
Italy 0,21%
Brazil 0,2%
Data as of 01/12/2021, Source: Lyxor International Asset Management

CHARACTERISTICS

Main Fund Characteristics

ISIN LU2023678282
Assets Under Management 217,1mio GBP
UCITS Yes
Total Expense Ratio 0,45%
Tax data (PEA) No
EU-SD Status Out of Scope
Fund Type SICAV
Domicile Luxembourg
Replication Method Direct (Physical)
Sampling No
Securities Lending No
Portfolio Managers Raphaël Dieterlen, Salah BENAISSSA
Share Class Currency USD
Dividend Treatment Capitalisation
Umbrella AUM 10 980,6mio GBP
Financial Year End 31/10/2022
Inception Date 02/03/2020
Minimum Investment 1 Share
SFDR Classification 8

DISCLAIMER: This fund includes a risk of capital loss. Investors therefore may not recover all or part of their initial investment. The redemption value of this fund may be less than the amount initially invested. In a worst case scenario, investors could sustain the loss of their entire investment. Be sure to read carefully the Key Investor Information document, and the “risk factors” section of a fund’s performance to better understand the risks involved.

Trading Information

Exchange Ticker Bloomberg Listing Currency Currency Hedged Listing Date Dividend Policy ADV 3M ISIN Fund AUM in CCY
Euronext UNIC FP EUR - 21/04/2020 Capitalisation 67 619EUR LU2023678282 254mio EUR
Xetra DRUP GY EUR - 30/04/2020 Capitalisation 348 681EUR LU2023678282 254mio EUR
Borsa Italiana UNIC IM EUR - 30/04/2020 Capitalisation 797 379EUR LU2023678282 254mio EUR
BMV UNICN MM MXN - 18/05/2021 Capitalisation - LU2023678282 6 108mio MXN
LSE DTEC LN GBP - 30/04/2020 Capitalisation 27 408GBP LU2023678282 216mio GBP
LSE UNIC LN USD - 30/04/2020 Capitalisation 47 930USD LU2023678282 287mio USD
SIX Swiss Ex QBIT SW CHF - 23/04/2020 Capitalisation 27 667CHF LU2023678282 264mio CHF
*Related Shareclasses

Market Makers

Flow Traders
Optiver
Société Générale
Data provided by relevant exchanges

Passporting Information

UK
Spain
France
Germany
Belgium
Netherlands
Italy
Switzerland
Luxembourg
Austria
Sweden
Finland
Norway
Denmark
Korea
Data as of 01/12/2021, Source: Lyxor International Asset Management

NEWS

Corporate
03/11/2021

Corporate ESG @ Lyxor ETF – our new digital handbook

Lyxor in the Media
19/10/2021

Lyxor in the Media Video: Lyxor’s sustainable thematic ETFs

Blog
15/04/2021

Blog Disruptive Technology vlog: invest in tomorrow’s giants, today

Notice to Shareholders
28/01/2021

Notice to Shareholders Annual general meeting of Lyxor Index Fund

Diversify product range icon

See the range

Diversify